OxyContin and Oxycodone Birth Defects

Brand name OxyContin and its generic oxycodone is a narcotic drug that was approved by FDA in 1995 for the treatment of moderate to severe pain. OxyContin contains oxycodone HCl, an opioid with an addiction potential similar to that of morphine. Before any drug is approved for marketing in the United States, the FDA must decide whether the studies submitted by the manufacturer have adequately demonstrated that the drug is safe and effective under the conditions of use in the drug's labeling. No drug is totally safe. Patients should be assessed for their clinical risks for opioid abuse or addiction prior to being prescribed opioids. Consistent with some previous investigations, the ongoing National Birth Defects Prevention study shows an association between early pregnancy maternal opioid analgesic treatment and certain birth defects. This information should be considered by women and their doctors who make treatment decisions during pregnancy. Statistically significant associations with maternal opioid use were found among infants with conoventricular, atrioventricular, and atrial septal defect (not otherwise specified); hypoplastic left heart syndrome; tetralogy of Fallot; or pulmonary valve stenosis. We found a significant association between maternal opioid use between one month before and three months after conception. Were you prescribed oxycodone or OxyContin for pain and not notified about birth defect risks? Do you have a birth defect lawsuit?  
Error: Unable to create directory /srv/www/fda-reports.com/public_html/alerts/wp-content/uploads/2015/10. Is its parent directory writable by the server?

About Michael Monheit

Michael Monheit is the managing lawyer at Monheit Law, outside Philadelphia, Pennsylvania. He is also the managing attorney in charge of all Internet business development for the law firm of Anapol Schwartz. Mr. Monheit currently is the chairman of the Fosamax Litigation Group for the American Association for Justice, and he serves on the AAJ Marketing and Client Services Committee. During his legal career, Michael Monheit has successfully prosecuted thousands of cases; at present, he is focusing his practice on complex cases involving defective health care and pharmaceutical products.
This entry was posted in Birth Defects.